Braskem(US:BAK)2026-03-27 11:12Financial Performance - Braskem S.A. reported a net loss of R$ 10,961 million in the consolidated financial statements for the year ended December 31, 2025[10]. - Consolidated net revenue for 2025 was R$70,717 million, a decrease of 8.9% from R$77,411 million in 2024[35]. - Gross profit for 2025 was R$1,556 million, down 74.0% from R$5,997 million in 2024[35]. - The company reported a loss for the year of R$10,961 million in 2025, compared to a loss of R$12,052 million in 2024, showing an improvement of 9.1%[37]. - Total comprehensive loss for the year was R$12,190 million in 2025, compared to R$9,643 million in 2024, indicating a worsening of 26.0%[37]. - The company’s accumulated losses increased to R$23,902 million in 2025 from R$14,034 million in 2024[34]. - The company recorded a loss before income tax of R$2,845 million in 2025, compared to a loss of R$17,733 million in 2024[42]. - The net profit from Braskem Holanda decreased to R$ 1,065 million in 2025 from R$ 1,519 million in 2024, a decline of 29.8%[159]. Assets and Liabilities - The company's current liabilities exceeded total assets by R$ 9,770 million in the consolidated balance sheet as of December 31, 2025[10]. - Total assets decreased to R$81,879 million in 2025 from R$101,575 million in 2024, representing a decline of 19.4%[34]. - Total liabilities increased to R$58,163 million in 2025 from R$77,581 million in 2024, a decrease of 25.0%[34]. - The company has a negative equity of R$ 16,502 million in the consolidated financial statements as of December 31, 2025[10]. - As of December 31, 2025, Braskem Idesa's outstanding bond liabilities were reclassified to current liabilities, totaling R$ 12,083 million, due to default on interest payments[58]. - The total liabilities for Braskem S.A. were R$ 44,385 million at December 31, 2025, a decrease from R$ 44,755 million at December 31, 2024[144]. Impairment and Asset Valuation - The impairment tests for the Petrochemical complex Braskem Idesa resulted in an impairment loss of R$ 1,287 million for property, plant, and equipment, R$ 49 million for intangible assets, and R$ 100 million for right-of-use assets[15]. - The company performed impairment tests at least annually for cash-generating units containing goodwill related to future profitability[14]. - The impairment testing revealed a total impairment loss of R$2,097 million, with significant losses in the Braskem Idesa segment amounting to R$1,366 million[197]. - The company recognized an impairment loss of R$ 1,468 million due to the recoverable amounts of its assets being lower than their carrying amounts[66]. - The company recognized impairment losses totaling R$781 million due to mothballing assets related to chlorine and caustic soda production[91]. Cash Flow and Liquidity - The company’s cash and cash equivalents decreased to R$10,501 million in 2025 from R$14,986 million in 2024, a decline of 29.8%[32]. - Cash generated from operating activities decreased to R$442 million in 2025 from R$7,331 million in 2024[42]. - Braskem's net cash used in investing activities was R$2,947 million in 2025, compared to R$3,485 million in 2024[42]. - Total debt payments amounted to R$1,685 million in 2025, down from R$4,994 million in 2024[42]. - The company is facing a prolonged downturn in the petrochemical industry, with cash consumption associated with debt service and recurring interest payments impacting liquidity[74]. Regulatory and Market Environment - In December 2025, the Brazilian government enacted Law No. 15,294/25, establishing the PRESIQ program to support the chemical industry, effective from January 1, 2027, to December 31, 2031[70]. - A provisional antidumping duty was approved in August 2025 for polyethylene resins imported from the U.S. and Canada, aimed at protecting the domestic industry[71]. - The Brazilian tax reform, effective from 2026, introduces a dual VAT model, with the company preparing for compliance adjustments[92]. - The company is monitoring geopolitical tensions affecting energy markets, which have led to increased volatility in international prices of resins and chemical products[95]. Corporate Governance and Management - Management's plans regarding the company's ability to continue as a going concern are detailed in the financial statements[10]. - The auditor's report indicates that the financial statements present fairly the financial position and performance of Braskem S.A. in accordance with Brazilian and IFRS standards[9]. - The company engaged financial and legal advisors in September 2025 to explore economic and financial alternatives for capital structure reorganization[67]. - The company is in negotiations regarding a potential corporate transaction involving its controlling shareholder, with approvals pending from competition authorities in Mexico and the EU[82]. Research and Development - Research and development expenses were R$460 million in 2025, a marginal decrease from R$463 million in 2024[35]. - The company has initiated steps to convert its chlor-alkali plant in Alagoas to handle ethylene dichloride, enhancing competitiveness in PVC production[88]. Inventory and Receivables - Finished goods inventory decreased to R$ 6,093 million in 2025 from R$ 7,586 million in 2024, reflecting a reduction of 19.6%[137]. - Total inventories amounted to R$ 10,421 million in 2025, down from R$ 13,688 million in 2024, indicating a decline of 23.5%[137]. - Trade accounts receivable as of December 31, 2025, totaled R$ 3,455 million, a slight decrease from R$ 3,562 million in 2024[132]. - The expected credit losses (ECL) for trade accounts receivable increased to R$ 173 million in 2025 from R$ 70 million in 2024[135]. Investments and Divestitures - The total investments in subsidiaries decreased to R$ 22,570 million in 2025 from R$ 29,164 million in 2024, a reduction of 22.5%[164]. - Braskem Netherlands divested its entire interest in B&TC and ER Plastics, resulting in a loss of R$96 million recorded under other expenses[105]. - The company divested its entire stake in B&TC and ER Plastics in June 2025, aligning with its strategic direction[160]. Financial Reporting and Standards - The financial statements are presented in Brazilian Reais (R$), with all amounts rounded to the nearest million[112]. - The company identified recurring EBITDA as a management performance measure to be disclosed upon initial adoption, impacting the presentation of the Statement of Cash Flows[120]. - New standards effective from January 1, 2025, include amendments to IAS 21 and OCPC 10, which do not affect the company as it does not conduct operations in non-convertible currencies[113]. - The amendments to IFRS 18/CPC 51 will require the presentation of operating profit and profit before financing and income taxes, improving clarity and comparability of disclosed information[114].